Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
12/2000
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/12/2000US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160021 Administering to the subject a treatment which modulates the level of nitric oxide in the skin
12/07/2000WO2000073791A1 Remedies for kidney diseases and method for screening the same
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073510A1 iETHOD OF TRANSPOSON-MEDIATED MUTAGENESIS IN THE NEMATODE CAENORHABDITIS ELEGANS
12/07/2000WO2000073500A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
12/07/2000WO2000073460A2 Modified cytokine for its stabilisation
12/07/2000WO2000073453A1 T-bet compositions and methods of use thereof
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000072671A1 Method of feeding ants and a food dispenser for the purpose
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375050A1 T-bet compositions and methods of use thereof
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2372566A1 Modified cytokine for its stabilisation
12/06/2000EP1056840A1 Trans-somatics with gene transfer into mammary epithelial cells
12/06/2000EP1056336A1 Selection of mature sperm by surface membrane determinants
12/06/2000EP0729506A4 Myocardial grafts and cellular compositions useful for same
12/05/2000US6156952 Transgenic rat whose genome contains human immunodeficiency virus type-1 proviral dna with gag and pol genes mutated to render the dna noninfectious; model of symptoms of acquired immune deficiency syndrome; drug screening
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156574 Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof
12/05/2000US6156569 Prolonged culturing of avian primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156498 Establishment of HHV-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting HHV-8 infection
12/05/2000US6156306 Administering nucleic acid encoding adenovirus; genetic engineering
11/2000
11/30/2000WO2000071728A1 Recombinant bacterial phytases and uses thereof
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071575A1 Models of prion disease
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000047610A3 Method for altering undesirable immune responses to polypeptides
11/30/2000WO2000044768A3 Methods of isolating the androgenic sex hormone from crustacean prawn and marine shrimp and methods of use
11/30/2000WO2000040700A3 Oocyte activation by sperm components
11/30/2000WO2000032772A9 Erythropoietic compounds
11/30/2000WO2000024415A9 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000CA2374532A1 Recombinant bacterial phytases and uses thereof
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2374019A1 Models of prion disease
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/29/2000EP1055366A1 Use of transgenic mice lacking jun-b expression in the myeloid lineage
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000CN1274525A Automatic industrial cultivation of forest frog
11/28/2000US6153428 α(1,3) galactosyltransferase negative porcine cells
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000069791A1 Installation for recycling waste from stock-raising using fly larvae
11/23/2000WO2000069451A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000WO2000069268A1 Production of human cells, tissues, and organs in animals
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000040711A8 Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon
11/23/2000WO2000036910A9 Msh5 ablated mice and uses therefor
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000028011A3 Fk506-based regulation of biological events
11/23/2000WO2000026357A3 Transgenic and cloned mammals
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000CA2373935A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/22/2000EP1053677A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes
11/22/2000EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053340A1 Genetic manipulation of spermatogonia
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
11/22/2000EP1053309A1 Compositions and methods for wound healing
11/22/2000EP1053251A1 The aiolos gene
11/21/2000US6150583 Transgenic animals expressing artificial epitope-tagged proteins
11/21/2000US6150169 Inserting a coding sequence into a target endogenous gene in a mouse embryonic stem cell genome by transforming with vector having specific dna construct and allowing homologous recombination
11/21/2000US6150126 Daphnia reproductive bioassay for testing toxicity of aqueous samples and presence of an endocrine disrupter
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6149867 Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
11/16/2000WO2000068691A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities
11/16/2000WO2000068399A2 Vector-mediated delivery of integrating transposon sequences
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068361A1 Versican and epithelial-mesenchymal interaction
11/16/2000WO2000068268A1 Human gabab receptor 1 promoters
11/16/2000WO2000067839A1 Method and apparatus for inducing ventricular arrhythmias in test animals
11/16/2000WO2000067803A1 Compositions and methods for improving learning and memory
11/16/2000WO2000067569A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000067568A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000034493A3 Regulatory sequences of the mouse villin gene - use in transgenesis
11/16/2000WO2000031237A3 Method of cloning porcine animals
11/16/2000WO2000025578A3 Methods for cloning animals
11/16/2000CA2373617A1 Compositions and methods for improving learning and memory
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372635A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000CA2372597A1 Human gabab receptor 1 promoters
11/16/2000CA2371219A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities